Erytech Pharma S.A.: ERYTECH Provides Regulatory Update : vi

ERYTECH Provides Regulatory Update ERYTECH to stop further plans to pursue a BLA submission seeking an approval for Graspa in hypersensitive ALLEvaluation of strategic partnering options

Related Keywords

France , United States , Cambridge , Cambridgeshire , United Kingdom , Paris , France General , New Jersey , American , Gil Beyen , Mathilde Bohin Louis Victor Delouvrier , Nicolas Merigeau , Pharma Bio , Eric Soyer , Company Securities , Drug Administration , Exchange Commission , Company Annual Report On Form , American Society Of Hematology , Nordic Organization For Paediatric Haematology , Euronext , Chief Executive Officer , Fast Track , Nordic Organization , Paediatric Haematology , Biologics License Application , Initial Pediatric Study Plan , Nasdaq Global Select Market , Next Biotech , Nasdaq Global Select , French Autorit , Des March , Registration Document , Annual Report , Erytech , Dharma , Rovides , Egulatory , Update ,